1,806
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Potential nephroprotective effects of the Chinese herb Angelica sinensis against cisplatin tubulotoxicity

, , , &
Pages 985-994 | Received 20 Jan 2014, Accepted 17 Jul 2014, Published online: 11 Dec 2014

References

  • Anonymous. (2011). FlowJo, data analysis software for flow cytometry. In: FlowJo Advanced Tutorial. 7.6.2 ed. Ashland: Tree Star Inc
  • Barabas K, Milner R, Lurie D, Adin C. (2008). Cisplatin: A review of toxicities and therapeutic applications. Vet Comp Oncol 6:1–18
  • Bozic M, De Rooij J, Parisi E, et al. (2011). Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. J Am Soc Nephrol 22:1099–111
  • Bucaloiu ID, Kirchner HL, Norfolk ER, et al. (2012). Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 81:477–85
  • Bunel V, Antoine MH, Nortier J, et al. (2014). Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro. J Appl Toxicol 34:1311–19
  • Chao WW, Lin BF. (2011). Bioactivities of major constituents isolated from Angelica sinensis (Danggui). Chin Med 6:1–7
  • Choy YM, Leung KN, Cho CS, et al. (1994). Immunopharmacological studies of low molecular weight polysaccharide from Angelica sinensis. Am J Chin Med 22:137–45
  • Council of Europe. (2013). European Pharmacopoeia. Strasbourg: Tec & Doc
  • Cummings BS, Schnellmann RG. (2002). Cisplatin-induced renal cell apoptosis: Caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302:8–17
  • Docherty NG, O’Sullivan OE, Healy DA, et al. (2006). TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 290:F1202–12
  • Dos Santos NA, Carvalho Rodrigues MA, Martins NM, Dos Santos AC. (2012). Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update. Arch Toxicol 86:1233–50
  • Geback T, Schulz MM, Koumoutsakos P, Detmar M. (2009). TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265–74
  • Gottardi CJ, Gumbiner BM. (2004). Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 167:339–49
  • Hao S, He W, Li Y, et al. (2011). Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22:1642–53
  • Havasi A, Borkan SC. (2011). Apoptosis and acute kidney injury. Kidney Int 80:29–40
  • He W, Kang YS, Dai C, Liu Y. (2011). Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22:90–103
  • Hsiao CY, Hung CY, Tsai TH, Chak KF. (2012). A study of the wound healing mechanism of a Traditional Chinese Medicine, Angelica sinensis, using a proteomic approach. Evid Based Complement Alternat Med 2012:467531
  • Hu Q, Noor M, Wong YF, et al. (2009). In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transpl 24:3033–41
  • Jamieson ER, Lippard SJ. (1999). Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467–98
  • Lee SB, Kalluri R. (2010). Mechanistic connection between inflammation and fibrosis. Kidney Int 78:S22–6
  • Li X, Wang H. (2005). Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis 12:276–81
  • Lieberthal W, Triaca V, Levine J. (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am J Physiol 270:F700–8
  • Lin B. (2011). Polyphenols and neuroprotection against ischemia and neurodegeneration. Mini Rev Med Chem 11:1222–38
  • Liu Y. (2006). Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 69:213–17
  • Liu Y. (2010). New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212–22
  • Low Dog T. (2005). Menopause: A review of botanical dietary supplements. Am J Med 118:98–108
  • Megyesi J, Andrade L, Vieira JM Jr, et al. (2002). Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 283:F810–16
  • Meng LQ, Tang JW, Wang Y, et al. (2011). Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. Br J Pharmacol 162:1805–18
  • Nagwani S, Tripathi YB. (2010). Amelioration of cisplatin induced nephrotoxicity by PTY: A herbal preparation. Food Chem Toxicol 48:2253–8
  • Nitha B, Janardhanan KK. (2008). Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice. Food Chem Toxicol 46:3193–9
  • Pabla N, Dong Z. (2008). Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int 73:994–1007
  • Pozdzik AA, Salmon IJ, Debelle FD, et al. (2008). Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 73:595–607
  • Ruszymah BH, Chowdhury SR, Manan NA, et al. (2012). Aqueous extract of Centella asiatica promotes corneal epithelium wound healing in vitro. J Ethnopharmacol 140:333–8
  • Ryan MJ, Johnson G, Kirk J, et al. (1994). HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48–57
  • Sohn SH, Lee H, Nam JY, et al. (2009). Screening of herbal medicines for the recovery of cisplatin-induced nephrotoxicity. Environ Toxicol Pharmacol 28:206–12
  • Urruticoechea A, Smith IE, Dowsett M. (2005). Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 23:7212–20
  • Valcu M, Valcu CM. (2011). Data transformation practices in biomedical sciences. Nat Methods 8:104–5
  • Wang H, Li J, Yu L, et al. (2004). Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci 74:1645–58
  • WHO. (2004). WHO Monographs on Selected Medicinal Plants. Geneva: World Health Organization
  • Wojcikowski K, Wohlmuth H, Johnson DW, et al. (2009). An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects. Nephrology 14:70–9
  • Wynn TA. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524–9
  • Wynn TA. (2010). Fibrosis under arrest. Nat Med 16:523–5
  • Xu Q, Norman JT, Shrivastav S, et al. (2007). In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents. Am J Physiol Renal Physiol 293:F631–40
  • Yan R, Ko NL, Li SL, et al. (2008). Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat. Drug Metab Dispos 36:400–8
  • Yang L, Besschetnova TY, Brooks CR, et al. (2010). Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16:535–43. 1 p following 143
  • Yang WJ, Li DP, Li JK, et al. (2009). Synergistic antioxidant activities of eight traditional Chinese herb pairs. Biol Pharm Bull 32:1021–6
  • Yao X, Panichpisal K, Kurtzman N, Nugent K. (2007). Cisplatin nephrotoxicity: A review. Am J Med Sci 334:115–24
  • Ye YN, Koo MW, Li Y, et al. (2001). Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sci 68:961–8
  • Yu F, Li H, Meng Y, Yang D. (2013). Extraction optimization of Angelica sinensis polysaccharides and its antioxidant activity in vivo. Carbohydr Polym 94:114–19
  • Zeisberg M, Duffield JS. (2010). Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247–53
  • Zeisberg M, Neilson EG. (2009). Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429–37

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.